1. Home
  2. LITB vs GANX Comparison

LITB vs GANX Comparison

Compare LITB & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightInTheBox Holding Co. Ltd.

LITB

LightInTheBox Holding Co. Ltd.

N/A

Current Price

$2.88

Market Cap

58.2M

ML Signal

N/A

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

N/A

Current Price

$1.12

Market Cap

52.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LITB
GANX
Founded
2007
2017
Country
Singapore
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.2M
52.2M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
LITB
GANX
Price
$2.88
$1.12
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $7.20
AVG Volume (30 Days)
3.3K
★ 586.3K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.46
EPS
★ N/A
N/A
Revenue
N/A
★ $55,180.00
Revenue This Year
$4.36
N/A
Revenue Next Year
$3.80
N/A
P/E Ratio
$10.96
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.63
$1.14
52 Week High
$3.89
$4.34

Technical Indicators

Market Signals
Indicator
LITB
GANX
Relative Strength Index (RSI) 30.51 28.12
Support Level $2.33 N/A
Resistance Level $2.66 $2.01
Average True Range (ATR) 0.10 0.11
MACD -0.02 -0.01
Stochastic Oscillator 0.00 4.26

Price Performance

Historical Comparison
LITB
GANX

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is a e-commerce company, providing a diverse range of affordable lifestyle products directly to consumers. Its brands include Ador, a women's fashion brand targeting women aged 35-55; the second is a golf apparel brand focusing on female golfers aged 35 and above; the third is a women's light party dress brand for the age group of 30 and above. It offers customers products through websites and mobile applications. The company operates and reviews its performance in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of the provision of logistic services to companies and individual customers.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: